Main Article Content

Mai Syaroh Nasution
Wiryanto Wiryanto
Grace Wangge

Page: 716-727

Abstract

Pharmacovigilance safeguards patient safety, yet hospital ADR reporting in North Sumatra remains limited. This research to assess compliance with BPOM’s 10 completeness criteria and identify determinants that support or hinder implementation. Methods: A mixed methods approach with a sequential explanatory design was applied. descriptive analysis of 2019-2024 e-MESO reports and in-depth interviews with hospitals categorized as Complete, Incomplete, and Non-reporting. Results: Out of 210 hospitals, only 11 (5%) actively reported through e-MESO, producing 50 reports, 98% complete and 2% incomplete. About 74% were spontaneous reports, mostly skin reactions, with 40% serious cases in elderly patients. Qualitative analysis revealed seven main themes: understanding, reporting process, barriers, management support, e-MESO system, expectations, and interprofessional collaboration. Conclusion: While individual report completeness is high, system-level participation is low, so full compliance with the 10 criteria is not yet achieved. Reporting quality is largely shaped by managerial support, organizational readiness, and interprofessional collaboration. Recommended actions include expanding SOP-based reporting on the 10 criteria, appointing a clinical pharmacist as the person-in-charge, conducting cross-profession training, and coordinating e-MESO technical issues with BPOM particularly strengthening type-C hospitals.

Downloads

Download data is not yet available.

Article Details

How to Cite
Nasution, M. S., Wiryanto , W., & Wangge , G. (2026). Study of the Pharmacovigilance Reporting System Based on Hospital Reporting in North Sumatra from 2019-2024. Journal of Pharmaceutical and Sciences, 9(1), 716–727. https://doi.org/10.36490/journal-jps.com.v9i1.1212
Section
Original Articles

References

Nofiarny D. Pengenalan farmakovigilans: Apa dan mengapa diperlukan. Medicinus 2016;29:53–6.

Fadhilah H, Salman S, Hilmi IL. Review Artikel: Studi Farmakovigilans terhadap Kejadian Advers Drug Reactions (ADRs). Journal of Pharmaceutical and Sciences 2023:199–206.

Nasri N, Kaban VE, Gurning K, Tania CG. Pemeriksaan dan Pemberian Obat Anemia Kepada Ibu Hamil di Desa Kota Pari Pantai Cermin. ABDIKAN: Jurnal Pengabdian Masyarakat Bidang Sains Dan Teknologi 2022;1:351–7.

Bihan K, Lebrun-Vignes B, Funck-Brentano C, Salem J-E. Uses of pharmacovigilance databases: an overview. Therapies 2020;75:591–8.

Liviandari R, Husni P. Strategi Pencegahan dan Peningkatan Pengawasan BPOM Terkait Kasus Cemaran EG/DEG dalam Sirup Obat. Journal of Pharmaceutical and Sciences 2023:1906–11.

Widiyantoro S, Supendi P, Rawlinson N, Daryono MR, Rosalia S. A note on the seismicity of Sumatra, western Sunda Arc, Indonesia, in relation to the potential for back-arc thrusting. Scientific Reports 2024;14:13115.

Hauben M, Hung E. Effects of the COVID-19 pandemic on spontaneous reporting: global and national time-series analyses. Clinical Therapeutics 2021;43:360-368. e5.

Atoui A, Jarrah K, Al Mahmasani L, Bou-Fakhredin R, Taher AT. Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination. Ann Hematol 2022;101:1111–3. https://doi.org/10.1007/s00277-021-04743-1.

de Kuijper GM, Risselada A, van Dijken R. Monitoring drug side-effects. Handbook of Intellectual Disabilities: Integrating Theory, Research, and Practice, Springer; 2019, p. 275–301.

Anaba EL, Cole‐Adeife MO, Oaku RI. Prevalence, pattern, source of drug information, and reasons for self‐medication among dermatology patients. Dermatologic Therapy 2021;34:e14756.

Andriansyah Y, Neswita E, Razoki R. Administrative, Pharmaceutic And Clinical Study of Prescription Anti-Diabetes Drugs in One of Medan City Pharmacies. Jambura Journal of Health Sciences and Research 2022;4:740–7.

Dong Z, Tao Q, Sun G. Survey and analysis of the availability and affordability of essential drugs in Hefei based on WHO/HAI standard survey methods. BMC Public Health 2020;20:1405.

Creswell JW. Research design: Pendekatan metode kualitatif, kuantitatif dan campuran 2019.

Yuniar CT, Fadhilah RZ, Anggadiredja K, Amalia L. Healthcare Professionals Experiences on ADR reporting: A crosssectional survey in One Tertiary Hospital in Bandung, Indonesia. Drug Safety 2023;46:1186–7.

Osorio C, Garzón L, Jaimes D, Silva E, Bustos R-H. Impact on antibiotic resistance, therapeutic success, and control of side effects in therapeutic drug monitoring (TDM) of daptomycin: a scoping review. Antibiotics 2021;10:263.

Abduh M, Alawiyah T, Apriansyah G, Sirodj RA, Afgani MW. Survey Design: Cross Sectional dalam Penelitian Kualitatif. Jurnal Pendidikan Sains Dan Komputer 2023;3:31–9.

Kannel WB. Risk factors in hypertension. Journal of Cardiovascular Pharmacology 1989;13:S4–10.

Fossouo Tagne J, Yakob RA, Dang TH, Mcdonald R, Wickramasinghe N. Reporting, monitoring, and handling of adverse drug reactions in Australia: scoping review. JMIR Public Health and Surveillance 2023;9:e40080.

Cholifah N, Tristanti I. Hubungan Umur, Jenis Kelamin, Pekerjaan, Pendidikan Dengan Pharmacovigilance Program Pemberian Obat Filariasis Pada Warga Desa Pecangaan Kecamatan Batangan Kabupaten Pati. Proceeding Flurecol 2021:1089–92.

Lestari ND, Hastuti S, Astini N. Hubungan Lama Pengobatan Dan Jenis Obat Antiepilepsi Dengan Efek Samping Obat Pada Pasien Epilepsi Di Poliklinik Neurologi RSUDZA. Journal of Medical Science 2022;3:80–7.

Amida RU D. Kajian Farmakovigilans Terkait Efek Samping Obat Pada Pasien Gangguan Jiwa di Balai RSBKL Yogyakarta. STIKes Notokusumo Yogyakarta, 2025.

Ridansyah FYR. Gambaran Farmakovigilans Terkait Efek Samping Obat Pada Pasien Kanker Payudara di RSUD Kota Yogyakarta. STIKes Notokusumo Yogyakarta, 2025.

Rosalina AI. Kajian Distribusi, Keamanan Dan Pengembangan Kebijakan Obat Bebas Dan Bebas Terbatas. Jurnal Penelitian Dan Pengembangan Pelayanan Kesehatan 2021:20–30.

Sholihah I, Santoso J. Upaya Peningkatan Pengetahuan tentang Efek Samping Obat pada Warga Dasa Wisma dalam Upaya Penerapan Farmakovigilans. PaKMas: Jurnal Pengabdian Kepada Masyarakat 2021;1:142–6.

Yadav S, Sinha M, Taradia K, Sharma AK, Kulshreshtha M. Pharmacovigilance, cosmetovigilance, hemovigilance, and materiovigilance in healthcare domains. Journal of Medicine, Surgery, and Public Health 2025;5:100175.

SWP FA, Rahmawati F. Perilaku Apoteker Terhadap Pelaporan Efek Samping Obat. Journal Pharmacy Aisyah 2024;3:18–28.

Hermansyah O, Far S, Irawan Y, Farm S, Farm M. Manajemen Farmasi. Cendikia Mulia Mandiri; 2024.

Pertiwiwati E, Agianto SK, Rusli R. Kolaborasi Interprofesional: Membangun Budaya Keselamatan Pasien yang Kuat. Uwais Inspirasi Indonesia; 2025.

Nasri N, Kaban VE, Syahputra HD, Ginting JG, Tania CG. Peningkatan Pengetahuan Pola Hidup Bersih dan Sehat serta Penggunaan Vitamin pada Anak di Panti Asuhan Claresta. ABDIKAN: Jurnal Pengabdian Masyarakat Bidang Sains Dan Teknologi 2023;2:145–53.

Siregar B, Suripto B, Hapsoro D, Lo EW, Sugiyono F. Metode Penelitian Kombinasi (Mix Methods). Bandung: Alfabeta 2015.

Creswell JW, Creswell JD. Research design: Qualitative, quantitative, and mixed methods approaches. Sage publications; 2017.

Andari P, Handriyanto CF, Damayanti NA, Pudjirahardjo W. Recommendations to improve employee personal attitude toward reporting patient safety incidents. Jurnal administrasi kesehatan indonesia: Universitas Airlangga 2024;12:180–8.